Literature DB >> 7299851

Effect of taurine on seizures induced by 4-aminopyridine.

H Pasantes-Morales, M E Arzate.   

Abstract

The effect of intraperitoneally injected taurine against the convulsive activity induced by 4-aminopyridine (4-AP) was studied in 12- to 15-day-old mice. At a dose of 2.6 mg/kg, taurine increased the latency of clonic seizures from 7 to 20 minutes, reduced the incidence of tonic seizures from 92% to 30% and the postconvulsive mortality from 80% to 31%. The injection of EDTA prior to the administration of taurine prevented the protective effects of the amino acid. GABA and glycine at the same doses did not protect against 4-AP-induced seizures. 4-AP caused a small increase (19%) in 45Ca accumulation by mice brain synaptosomes incubated in a Krebs-HEPES medium containing low CaCl2 (0.1 mM) and also slightly potentiated the veratrine and potassium-induced increase in calcium accumulation. 4-AP at concentrations of 1-2 mM caused a marked increase (100%-500%) of 45 Ca accumulation by synaptosomes incubated in a Krebs-bicarbonate medium containing 2.5 mM CaCl2. This increase was completely antagonized by taurine but not by GABA of glycine. The present observations suggest that the anticonvulsant effect of taurine might be mediated by 4-AP-calcium-taurine interactions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7299851     DOI: 10.1002/jnr.490060404

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  6 in total

1.  Activation of beta-adrenergic receptors stimulates taurine release from glial cells.

Authors:  W G Shain; D L Martin
Journal:  Cell Mol Neurobiol       Date:  1984-06       Impact factor: 5.046

2.  Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia.

Authors:  Ming Sun; Chao Xu
Journal:  Cell Mol Neurobiol       Date:  2007-08-22       Impact factor: 5.046

3.  Anticonvulsant effects of some inhibitory neurotransmitter amino acids.

Authors:  E Toth; A Lajtha; S Sarhan; N Seiler
Journal:  Neurochem Res       Date:  1983-03       Impact factor: 3.996

Review 4.  Neuroprotective strategies against calpain-mediated neurodegeneration.

Authors:  Aysegul Yildiz-Unal; Sirin Korulu; Arzu Karabay
Journal:  Neuropsychiatr Dis Treat       Date:  2015-02-05       Impact factor: 2.570

Review 5.  Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms.

Authors:  Md Jakaria; Shofiul Azam; Md Ezazul Haque; Song-Hee Jo; Md Sahab Uddin; In-Su Kim; Dong-Kug Choi
Journal:  Redox Biol       Date:  2019-05-21       Impact factor: 11.799

6.  Electrophoretic drug delivery for seizure control.

Authors:  Christopher M Proctor; Andrea Slézia; Attila Kaszas; Antoine Ghestem; Isabel Del Agua; Anna-Maria Pappa; Christophe Bernard; Adam Williamson; George G Malliaras
Journal:  Sci Adv       Date:  2018-08-29       Impact factor: 14.136

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.